Fig. 5: Percentage of identified MRSA cases by screening “high-risk" patients.

For each patient in the UVA ICUs, we use each method to estimate their MRSA infection probability and rank them according to this probability from high to low. We then screen different percentages of patients (x-axis) and see how many actual MRSA cases can be forecasted (y-axis). As seen in the figure, NeurABM can always identify more MRSA cases than other baselines.